Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZOFRAN ODT
- Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy
- Ondansetron, Baclofen and Gabapentin in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery
- Examining the Effect of Ondansetron on Bowel Prep Success
- Inhaled Isopropyl Alcohol for Treatment of Nausea
- Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
- Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
- PROUD Study - Preventing Opioid Use Disorders
- Smooth Extubation With Magnesium Sulphate for General Anesthesia With Endotracheal Intubation
- Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP
- Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
- The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis
- Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery
- Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
- Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
- Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
- Cisplatin Disposition and Kidney Injury
- Restricted Fluid Therapy in Colorectal Surgery
- Pharmacogenomics and Post-Operative Nausea and Vomiting
- A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents
- Effect of Ketorolac on Post Adenotonsillectomy Pain
- Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
- Pain Management of ACL Reconstruction
- Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
- Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
- Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
- Prevention of Post Mastectomy With Intraoperative Ketamine
- Post-Operative Therapy for Nausea or Vomiting
- Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
- Triage Administration of Ondansetron for Gastroenteritis in Children
- Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
- Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department
- Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting
- Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
- CSF Pharmacokinetics of Ondansetron
- The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia
- Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery
- Aromatherapy for Postoperative Nausea and Vomiting in Children
- The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
- Dexmedetomidine and Desflurane Consumption
- EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron
- Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA
- Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
- Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
- The Effects of Ondansetron on Brain Function
- Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial
- 5-HT3 Antagonists (Antiemetics) and Cardiac Safety
- A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion
- Anesthetics in Rhytidoplasty - A Comparison Study
- Silodosin Versus Tamsulosin for Treatment of Ureteral Stones
- Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
- Preoperative Oral Dexamethasone to Improve Recovery After Surgery
- Decreasing Narcotics in Advanced Pelvic Surgery
- Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)
- The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients
- Ondansetron for Bipolar Disorder and Alcohol Use Disorders
- Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
- The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery
- Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron
- The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery
- Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
- Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic?
- Heart Safety Study of Ondansetron in Children Receiving Chemotherapy
- Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan
- Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan
- Emergency Department (ED) Drug Interaction in Emergency Department Patients
- The Effect of Ondansetron on Cardiac Output in Elective Cesarean Deliveries
- Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy
- Ondansetron for Pediatric Mild Traumatic Brain Injury
- Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
- How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women
- Ondansetron and the QT Interval In Adult Emergency Department Patients
- Propofol Versus Sevoflurane Recovery After Gynecological Surgery
- Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
- A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)
- Improving Tolerance of Treatment of Pulmonary MAC Infections
- Analgesic Effect of IV Acetaminophen in Tonsillectomies
- Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy
- Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
- Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)
- Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)
- Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2
- Pharmacogenetic Treatments for Alcoholism
- Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
- Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition
- Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers
- 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
- Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
- Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions
- Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions
- Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition
- Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition
- A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
- Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
- Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
- To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
- Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
- Non-opioid Analgesia for Fast-track Surgery
- Symptomatic Treatment of Acute Gastroenteritis
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
- Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water
- Two Way Bioequivalence Study Under Fed Conditions
- Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets
- Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)
- Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting
- Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human Volunteers
- Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
- Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)
- Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
- Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
- Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions
- Late Onset Postoperative Nausea and Vomiting
- Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
- Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
- Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)
- A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)
- A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)
- Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)
- Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
- Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia
- Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea
- Combined Pharmacotherapies for Alcoholism
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients
- Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)
- New Medication Treatment for Stimulant Dependence
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial
- Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery
- Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
- Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
- Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg
- Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg
- Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg
- Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg
- Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
- Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
- Multi-day Doses in Prevention of Nausea and Emesis
- Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
- Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
- A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
- Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
- Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study
- Ondansetron Reduce Vomiting Associated With Ketamine PSA
- Pharmacological Treatment for Alcoholism
- Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
- Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
- Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
- Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
- Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
- CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
- Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
- A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)
- Nexium Study To Suppress Nausea During Chemotherapy
- Post Burn Pruritus Study in Patients Undergoing Wound Healing
- A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
- Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
- Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
- Alcohol Dependency Study: Combining Medication Treatment for Alcoholism
- Ondansetron Treatment for Alcoholism
Clinical trials list
click for details